AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6689276
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration of salicylamide
Trial: 22584017
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral prednisone (6.25 mg/day) co-medication with methotrexate (MTX)
Trial: 16035056
Drug: Duloxetine 60-mg
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60-mg QD
Trial: 10534515
Drug: Clexane (enoxaparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clexane (enoxaparin sodium) 1 mg/kg body weight
Trial: 10534515
Drug: Clexane (enoxaparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clexane (enoxaparin sodium) 0.69 mg/kg (after dose reduction)
Trial: 10534515
Drug: Standard unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard unfractionated heparin
Trial: 7781662
Drug: Candoxatril treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatril treatment on high sodium diet
Trial: 7781662
Drug: Candoxatril treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatril treatment on low sodium diet
Trial: 2191189
Drug: Continuous intraperitoneal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intraperitoneal insulin (CIPII)
Trial: 31045840
Drug: Oxycodone 2×ED95
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 2×ED95 (0.182 mg/kg)
Trial: 31045840
Drug: Oxycodone ED95
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone ED95 (0.091 mg/kg)
Trial: 31045840
Drug: Oxycodone 0.269
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 0.269 mg/kg (recalculated ED95)
Trial: 28671089
Drug: 2% liranaftate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% liranaftate ointment
Trial: 23478248
Drug: N-acetyl cysteine
RxNorm normalized name: N-Acetyl Cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl cysteine (NAC) 600 mg plus three-drug regimen (pantoprazole 40 mg BD, ciprofloxacin 500 mg BD, bismuth subcitrate 120 mg two tablets BD)
Trial: 23478248
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus three-drug regimen (pantoprazole 40 mg BD, ciprofloxacin 500 mg BD, bismuth subcitrate 120 mg two tablets BD)
Trial: 15386160
Drug: 800 IU
RxNorm normalized name: Vitamin E 800 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 IU vitamin D3 plus 1 g calcium
Trial: 9044475
Drug: rt‐PA plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt‐PA plus heparin (H) (n = 10)
Trial: 9044475
Drug: Heparin (H)
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin (H) alone (n = 10)
Trial: 12544454
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg enalapril
Trial: 3630891
Drug: Aspirin pretreatment
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin pretreatment (3.6 mg/kg lysine salt of acetylsalicylic acid, corresponding to 2 mg/kg aspirin)
Trial: 24821586
Drug: linagliptin 5mg
RxNorm normalized name: LINAGLIPTIN 5MG TAB
DrugBank: Linagliptin (DB08882)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: linagliptin 5mg daily
Trial: 22552566
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ramipril 10 mg + telmisartan 80 mg)
Trial: 18711936
Drug: Corticosteroids (prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids (prednisolone 40 mg daily tapered to 5 mg over 12 weeks) + MB-MDT
Trial: 17045906
Drug: Inhaled treprostinil
RxNorm normalized name: treprostinil Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled treprostinil at 7.5 mug
Trial: 17045906
Drug: Inhaled treprostinil
RxNorm normalized name: treprostinil Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled treprostinil at 30 mug
Trial: 17045906
Drug: Inhaled treprostinil
RxNorm normalized name: treprostinil Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled treprostinil at 15 mug with varying pulses (18, 9, 3, 2, 1)
Trial: 10894582
Drug: Propofol (20‐120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (20‐120 mg) and fentanyl (0.25‐1.5 mg)
Trial: 10894582
Drug: Midazolam (2‐6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (2‐6 mg) and meperidine (25‐75 mg)
Trial: 3904410
Drug: Slow tapering
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow tapering of methadone
Trial: 31985746
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy with mean arterial blood pressure (MABP) less than 70 mm Hg for a minimum of 10 minutes
Trial: 31985746
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy with mean arterial blood pressure (MABP) less than 70 mm Hg for a continuous episode of minimum 20 minutes
Trial: 31985746
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy with mean arterial blood pressure (MABP) greater than 90 mm Hg for a minimum of 45 minutes
Trial: 31985746
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy with mean arterial blood pressure (MABP) greater than 90 mm Hg for a continuous episode of minimum 115 minutes
Trial: 24872027
Drug: Nicotine oral
RxNorm normalized name: nicotine Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine oral spray (1mg of nicotine free base per spray) plus nicotine patch
Trial: 24872027
Drug: Placebo spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo spray plus nicotine patch
Trial: 23649050
Drug: Dexamethasone 1
RxNorm normalized name: dexamethasone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 1 mg every 8 hours for 3 days
Trial: 23649050
Drug: Serratiopaptidase 10
RxNorm normalized name: serratiopeptidase 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serratiopaptidase 10 mg every 8 hours for 3 days
Trial: 15566926
Drug: Estrogen-progestin replacement
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen-progestin replacement therapy
Trial: 15828615
Drug: Minimal dose
RxNorm normalized name: Centipeda minima whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal dose of estrogens
Trial: 12461301
Drug: Chlorthalidone, 12.5-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone, 12.5-25 mg/d (n=15,255)
Trial: 12461301
Drug: Amlodipine, 2.5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine, 2.5-10 mg/d (n=9048)
Trial: 12461301
Drug: Lisinopril, 10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril, 10-40 mg/d (n=9054)
Trial: 10492100
Drug: Intensive regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive regimen (3000 microg dinoprostone given three times daily)
Trial: 10492100
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen (3000 microg dinoprostone once daily)
Trial: 8758286
Drug: Oral artemether
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral artemether (Art) 6 mg/kg followed by 3 repeated doses every 15 days
Trial: 6688500
Drug: High-dose dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dexamethasone sodium phosphate (0.6 mg/kg)
Trial: 23947690
Drug: Topical Arnica
RxNorm normalized name: ARNICA
DrugBank: Arnica montana flower (DB14343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Arnica
Trial: 11196518
Drug: Individually attended
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individually attended treatment
Trial: 7977319
Drug: r‐HuEPO (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐HuEPO (50 U/kg subcutaneously three times weekly)
Trial: 7977319
Drug: r‐HuEPO (treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐HuEPO (treatment group)
Trial: 30700564
Drug: Continuous Infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Infusion of Vancomycin (CIV)
Trial: 30700564
Drug: Intermittent Infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent Infusion of Vancomycin (IIV)
Trial: 21773588
Drug: Chicory inulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chicory inulin (20 g day(-1))
Trial: 10355845
Drug: Fat emulsion
RxNorm normalized name: FAT EMULSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat emulsion (30% of total calories) administered from day of operation to POD 7
Trial: 10355845
Drug: Glucose as
RxNorm normalized name: Publix Glucose Assorted Flavors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose as a non-protein calorie source administered from day of operation to POD 7
Trial: 7213520
Drug: Heroin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin (3 mg/70 kg)
Trial: 7213520
Drug: Heroin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin (6 mg/70 kg)
Trial: 7213520
Drug: Heroin (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin (12 mg/70 kg)
Trial: 8071850
Drug: Morphine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (10 mg/70 kg)
Trial: 7213520
Drug: Morphine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (20 mg/70 kg)
Trial: 30278495
Drug: 40 mL of
RxNorm normalized name: sodium bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 40 mL of 0.375% ropivacaine mixed with 1 μg/kg dexmedetomidine (group D)
Trial: 30278495
Drug: 40 mL of
RxNorm normalized name: sodium bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 40 mL of 0.375% ropivacaine (group C)
Trial: 26499503
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care provided by a certified diabetes-educator pharmacist
Trial: 12815800
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy with at least three drugs
Trial: 9813401
Drug: Gabapentin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (up to 2,400 mg/day)
Trial: 8878083
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g sorbitol and 20 g glucose
Trial: 8878083
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g sorbitol and 9 g lipids
Trial: 8878083
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g sorbitol alone
Trial: 7028921
Drug: Timolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (5 mg twice daily)
Trial: 30528828
Drug: Apremilast 40
RxNorm normalized name: Apremilast
DrugBank: Apremilast (DB05676)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Apremilast 40 mg twice daily (APR40)
Trial: 30528828
Drug: Apremilast 30
RxNorm normalized name: apremilast 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apremilast 30 mg twice daily (APR30)
Trial: 21372124
Drug: Sagopilone 16
RxNorm normalized name: Sagopilone
DrugBank: Sagopilone (DB12391)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sagopilone 16 mg/m² as a 3-h i.v. infusion every 21 days for up to 6 weeks
Trial: 21372124
Drug: Sagopilone 16
RxNorm normalized name: Sagopilone
DrugBank: Sagopilone (DB12391)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sagopilone 16 mg/m² as a 0.5-h i.v. infusion every 21 days for up to 6 weeks
Trial: 21372124
Drug: Sagopilone (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sagopilone (both infusion schedules)
Trial: 19998333
Drug: Standardized Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized Care group (SCG) - directed to a resource room for women with chemotherapy-related alopecia
Trial: 16393218
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of ketorolac trometamol (KT) administered intravenously as premedication 30 min prior to procedure
Trial: 16393218
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline) administered intravenously as premedication 30 min prior to procedure
Trial: 11925518
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (400% above the seizure threshold) right unilateral (RUL) ECT
Trial: 11925518
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose (150% above seizure threshold) RUL ECT
Trial: 11925518
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (just above seizure threshold) bifrontal (BF) ECT
Trial: 2667310
Drug: Urapidil (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (25 or 50 mg)
Trial: 55890
Drug: Methimazole 40
RxNorm normalized name: methimazole 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole 40 mg per day
Trial: 28244906
Drug: Weekly teriparatide
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly teriparatide administration for 6 months postoperatively
Trial: 25304755
Drug: Repeated dose
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated dose 4+8+4mg betamethasone
Trial: 25304755
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose 16mg betamethasone
Trial: 25304755
Drug: Betamethasone (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone (both doses)
Trial: 21223344
Drug: Certolizumab pegol
RxNorm normalized name: Certolizumab Pegol
DrugBank: Certolizumab pegol (DB08904)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Certolizumab pegol 400 mg every 2 weeks (q2w)
Trial: 21223344
Drug: Certolizumab pegol
RxNorm normalized name: Certolizumab Pegol
DrugBank: Certolizumab pegol (DB08904)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Certolizumab pegol 400 mg every 4 weeks (q4w)
Trial: 19947366
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (including mastectomy, neoadjuvant and adjuvant chemohormonal and radiotherapy)
Trial: 17854247
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of zonisamide and bupropion
Trial: 11304902
Drug: Alosetron 1
RxNorm normalized name: alosetron 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alosetron 1 mg p.o. bid
Trial: 9219782
Drug: Stonetome combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stonetome combination catheter
Trial: 7902021
Drug: Deflazacort 30
RxNorm normalized name: deflazacort 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort 30 mg/d
Trial: 7902021
Drug: Deflazacort 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort 60 mg/d
Trial: 7902021
Drug: Deflazacort 6
RxNorm normalized name: deflazacort 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort 6 mg/d
Trial: 27256922
Drug: MK‐1064 (OX2R
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK‐1064 (OX2R antagonist)
Trial: 27256922
Drug: Dual orexin
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual orexin receptor antagonists (for comparison)
Trial: 25614171
Drug: 3-month prednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month prednisolone treatment (0.5 mg·kg(‐1)·day(‐1) for 3 months, then tapered)
Trial: 25614171
Drug: 6-month prednisolone
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month prednisolone treatment (0.5 mg·kg(‐1)·day(‐1) for 6 months, then tapered)
Trial: 25614171
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (3-month and 6-month prednisolone)
Trial: 19056708
Drug: Newer antiretroviral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Newer antiretroviral therapies
Trial: 19056708
Drug: Earlier antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Earlier antiretroviral therapies
Trial: 10769553
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (1 g)
Trial: 10769553
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (1 g)
Trial: 10769553
Drug: Mepivacaine infiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine infiltration (0.2 ml of 1%)
Trial: 9314631
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro in combination with sulfonylureas
Trial: 11398073
Drug: Grass pollen
RxNorm normalized name: grass pollen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass pollen immunotherapy
Trial: 24336783
Drug: OAC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAC treatment in sinus rhythm (SR) subgroup
Trial: 21953589
Drug: Prednisolone 60
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone 60 mg/day
Trial: 21953589
Drug: Prednisolone 30
RxNorm normalized name: prednisolone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 30 mg/day
Trial: 18301121
Drug: Active treatments
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatments using the Sheehan Disability Scale (SDS)
Trial: 18301121
Drug: Inactive treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive treatments using the Sheehan Disability Scale (SDS)
Trial: 15496867
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (MgSO4) >or=50 g
Trial: 9474110
Drug: Home-based physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based physical therapy (5 sessions)
Trial: 9474110
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy strategies incorporated into interactive play activities
Trial: 7603607
Drug: 100 IU/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 IU/day daily for 30 days every other month (cyclically)
Trial: 7603607
Drug: Cyclic and
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic and continuous treatment groups at the same dosage
Trial: 7603607
Drug: S‐calcitonin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S‐calcitonin therapy cessation
Trial: 2743348
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg trazodone daily
Trial: 2743348
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg amitriptyline daily
Trial: 2743348
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg haloperidol daily
Trial: 2743348
Drug: placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo daily
Trial: 21174533
Drug: Bendamustine 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine 120 mg/m² on days 1 and 2 of each 21-day cycle for six to eight cycles
Trial: 2210673
Drug: Norfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (400 mg/day)
Trial: 17134849
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg L-dopa plus 100 mg carbidopa (Sinemet CR)
Trial: 17134849
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg L-dopa plus 200 mg carbidopa (Sinemet CR)
Trial: 7880610
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion (c.i.v.) of recombinant human IL-2 (rIL-2)
Trial: 7880610
Drug: Subcutaneous (s.c.)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (s.c.) injections of recombinant human IL-2 (rIL-2)
Trial: 7880610
Drug: Neutralising activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutralising activity in patients with anti-rIL-2 antibodies